As a result, although the proportion of patients receiving a biologic was higher in the non- F ENO suppressor group, this did not reach statistical significance.
← all excerpts
Suppression of <i>F</i> <sub>ENO</sub> with observed inhaled corticosteroid therapy in severe asthma: is it a useful test in clinical practice?
1
—
—